Alphatec Holdings, Inc. reported a 32% increase in total revenue, reaching $118 million for Q3 2023. Surgical revenue also grew by 32% to $104 million, and EOS revenue increased by 30% to $14 million. The company achieved positive adjusted EBITDA of over $2 million.
Total revenue increased by 32% to $118 million.
Surgical revenue grew by 32% reaching $104 million.
EOS revenue increased by 30% to $14 million.
Achieved positive adjusted EBITDA of over $2 million.
The Company continues to expect total revenue to grow 35% to $472 million for the fiscal year ended December 31, 2023. The Company now expects non-GAAP adjusted EBITDA of approximately $3 million for the full year 2023.
Analyze how earnings announcements historically affect stock price performance